Furong Liu

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0002-4806-1254

发表论文 45 篇 · 总被引 466 次 · h-index 11

代表论文

• Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial (2025 · The Lancet Oncology · 被引 61)
• An exploration of the breastfeeding behaviors of women after cesarean section: A qualitative study (2020 · International Journal of Nursing Sciences · 被引 38)
• Tumor-specific activated nano-domino-CRISPR to amplify intrinsic oxidative and activate endogenous apoptosis for spatiotemporally specific therapy (2023 · Biomaterials · 被引 27)
• Effects of a theory of planned behavior-based intervention on breastfeeding behaviors after cesarean section: A randomized controlled trial (2021 · International Journal of Nursing Sciences · 被引 26)
• CMG901, a Claudin18.2-specific antibody-drug conjugate, for the treatment of solid tumors (2024 · Cell Reports Medicine · 被引 23)
• Breaking the Tumor Chronic Inflammation Balance with a Programmable Release and Multi‐Stimulation Engineering Scaffold for Potent Immunotherapy (2024 · Advanced Science · 被引 18)